Results 311 to 320 of about 1,940,572 (373)
By employing a combination of single cell and spatial transcriptomic sequencing, this study presents a stereoscopic response of rice leaf to Magnaporthe oryzae infection. The vascular tissues mount defenses by producing phytoalexins. The immune strength is stronger toward the rice leaf tip than that of the leaf base.
Wei Wang+15 more
wiley +1 more source
The JN.1 variant of COVID-19: immune evasion, transmissibility, and implications for global health. [PDF]
Naveed Siddiqui A+2 more
europepmc +1 more source
Engineered Lactobacillus acidophilus (LH@LA) is developed via in situ polymerization to co‐load lactate oxidase (LOx) and horseradish peroxidase (HRP). This system preserves LA activity, evades macrophage phagocytosis, and synergizes LA metabolism with enzyme cascades to enhance immunity, reduce tumor ATP, suppress PD‐L1 expression and AKT‐mTOR ...
Liuzhou Mao+7 more
wiley +1 more source
Molecular mimicry as a mechanism of viral immune evasion and autoimmunity. [PDF]
Maguire C+7 more
europepmc +1 more source
In this study, a targeting PFKFB4 biomimetic codelivery system is developed to improve paclitaxel efficacy by inducing ferroptosis in SCLC. This system enhances immune cell infiltration and cytokine secretion, activating anti‐tumor immunity. Combined with anti‐PD‐L1, it boosts immune responses, offering a novel therapeutic strategy for overcoming ...
Xiang Liu+9 more
wiley +1 more source
Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. [PDF]
Ma Z+9 more
europepmc +1 more source
The study develops engineered exosomes (EmDEX@GA) for locoregional immunomodulation of tumor‐draining lymph node (TDLN). EmDEX@GA can actively target to TDLN and remodel its immunosuppressive microenvironment through the synergistic effects of PD‐1/PD‐L1 blockade and STING pathway activation, subsequently enhance anti‐tumor immunity and suppress tumor ...
Yizhen Wang+12 more
wiley +1 more source
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion. [PDF]
Ruan W+13 more
europepmc +1 more source
STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy
STING agonists show promise in preclinical studies in boosting an anti‐tumor response using the immune system. However, different limitations remain, and future research is needed to better understand how STING activation impacts the tumor microenvironment, identify effective combination strategies, and determine the best tumor types for STING agonist ...
Laura Gehrcken+3 more
wiley +1 more source